Research map: Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia

Back to the article

Papers in this map

  1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia · Shannon L. Maude · 2018 · 5822 citations · Cited by this paper
  2. How to Change the Role of Allogeneic Hematopoietic Cell Transplantation in Adults with B-Cell Acute Lymphoblastic Leukemia · Martina Canichella · 2026 · Cites this paper
  3. Establishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-Cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation · 2025 · Related
  4. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia · Shannon L. Maude · 2014 · 5491 citations · Cited by this paper
  5. Effect of Minimal Residual Disease Guided Posttransplant 6-Mercaptopurine and Methotrexate Maintenance on Prognosis in Children with High-Risk Acute Lymphoblastic Leukemia: A Single-Center Experience · Zühre Kaya · 2026 · Cites this paper
  6. Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I · 2025 · Related
  7. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia · Jae H. Park · 2018 · 2735 citations · Cited by this paper
  8. Beyond CD34 Selection: Past and Emerging Strategies in Graft Manipulation in Allogeneic Stem Cell Transplantation · Gabriela Sanchez‐Petitto · 2026 · Cites this paper
  9. Acta Haematologica in the Era of Artificial Intelligence · 2026 · Related
  10. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide · Leo Luznik · 2008 · 1957 citations · Cited by this paper
  11. Comparison Allogeneic Hematopoietic Stem Cell Transplantation and Chemotherapy for Consolidation in Acute Lymphoblastic Leukemia In a Colombian Cohort. A Propensity Score Matching Analysis. · Juan Felipe Combariza · 2026 · Cites this paper
  12. Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis · 2026 · Related
  13. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study · Valentino Conter · 2010 · 795 citations · Cited by this paper
  14. Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection · 2026 · Related
  15. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis · Javier Bolaños‐Meade · 2023 · 601 citations · Cited by this paper
  16. Hans-Based Cell of Origin Is Not of Prognostic Significance in Diffuse Large B-Cell Lymphoma Patients: A Retrospective Single-Center Study Conducted in 326 RCHOP-Treated Patients · 2025 · Related
  17. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia · Donald A. Berry · 2017 · 597 citations · Cited by this paper
  18. A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia-Positive Acute Lymphoblastic Leukemia · 2026 · Related
  19. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies · Nicola Gökbuget · 2012 · 493 citations · Cited by this paper
  20. First Comprehensive Characterization of Lip Lymphoma: A Population-Based Study · 2026 · Related
  21. Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma · Marcelo C. Pasquini · 2020 · 452 citations · Cited by this paper
  22. International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes · 2026 · Related
  23. Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group · Stacey L. Berg · 2005 · 322 citations · Cited by this paper
  24. Effectiveness of Integrative Medicine in the Management of Lymphoma Survivors: An Exploratory Preference-Based Controlled Trial · 2026 · Related
  25. Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD · Benjamin K. Watkins · 2021 · 262 citations · Cited by this paper
  26. Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia · Nicholas James Short · 2016 · 260 citations · Cited by this paper
  27. Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia · Roman Pfeifer · 2012 · 233 citations · Cited by this paper
  28. Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features · Xian Zhang · 2020 · 223 citations · Cited by this paper
  29. Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial · Stephan Kadauke · 2021 · 213 citations · Cited by this paper
  30. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies · Leo Luznik · 2021 · 179 citations · Cited by this paper
  31. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant · Annalisa Ruggeri · 2016 · 142 citations · Cited by this paper
  32. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease · Veronika Bachanová · 2013 · 137 citations · Cited by this paper
  33. Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation · Sebastian Giebel · 2016 · 132 citations · Cited by this paper
  34. The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades · Elias Joseph Jabbour · 2023 · 118 citations · Cited by this paper
  35. The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis · Armin Ghobadi · 2022 · 94 citations · Cited by this paper
  36. Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia · Mahmoud Gaballa · 2021 · 92 citations · Cited by this paper
  37. Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial · Theodore Willis Laetsch · 2019 · 90 citations · Cited by this paper
  38. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review · Zabih Warraich · 2019 · 81 citations · Cited by this paper
  39. Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL · Neeraj Y. Saini · 2020 · 74 citations · Cited by this paper

Source: OpenAlex (CC0)